Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00639769What this trial is testingIrinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 41
Not applicableLooking for participantsNCT00898638What this trial is testingTissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 8,000
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT00458978What this trial is testingCediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more National Cancer Institute (NCI) 6
Not applicableStudy completedNCT00809016What this trial is testingPET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation TherapyWho this might be right forHead and Neck Cancer Centre Oscar Lambret 40
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00003809What this trial is testingCisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003565What this trial is testingDocetaxel in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00939627What this trial is testingPhase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent CetuximabWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00006036What this trial is testingLiposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forHead and Neck CancerLung CancerOvarian Cancer+1 more NCIC Clinical Trials Group 14
Not applicableStudy completedNCT00898664What this trial is testingDNA Analysis of Tissue Samples From Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 74
Not applicableStudy completedNCT00899769What this trial is testingBiomarkers in Patients With Head and Neck Cancer and in Healthy VolunteersWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00337129What this trial is testingS0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT00006471What this trial is testingFenretinide in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT00004261What this trial is testingEF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaWho this might be right forBreast CancerCervical CancerHead and Neck Cancer+2 more University Health Network, Toronto